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Abstract
Background: Most low-risk pregnant women receive the standard model of prenatal care with frequent office visits.
Research suggests that a reduced schedule of visits among low-risk women could be implemented without increasing
adverse maternal or fetal outcomes, but patient satisfaction with these models varies. We aim to determine the
effectiveness and feasibility of a new prenatal care model (OB Nest) that enhances a reduced visit model by
adding virtual connections that improve continuity of care and patient-directed access to care.
Methods and design: This mixed-methods study uses a hybrid effectiveness-implementation design in a single
center randomized controlled trial (RCT). Embedding process evaluation in an experimental design like an RCT
allows researchers to answer both “Did it work?” and “How or why did it work (or not work)?” when studying
complex interventions, as well as providing knowledge for translation into practice after the study. The RE-AIM
framework was used to ensure attention to evaluating program components in terms of sustainable adoption
and implementation.
Low-risk patients recruited from the Obstetrics Division at Mayo Clinic (Rochester, MN) will be randomized to OB
Nest or usual care. OB Nest patients will be assigned to a dedicated nursing team, scheduled for 8 pre-planned
office visits with a physician or midwife and 6 telephone or online nurse visits (compared to 12 pre-planned
physician or midwife office visits in the usual care group), and provided fetal heart rate and blood pressure home
monitoring equipment and information on joining an online care community.
Quantitative methods will include patient surveys and medical record abstraction. The primary quantitative outcome is
patient-reported satisfaction. Other outcomes include fidelity to items on the American Congress of Obstetricians and
Gynecologists standards of care list, health care utilization (e.g. numbers of antenatal office visits), and maternal and
fetal outcomes (e.g. gestational age at delivery), as well as validated patient-reported measures of pregnancy-related
stress and perceived quality of care. Quantitative analysis will be performed according to the intention to treat
principle. Qualitative methods will include interviews and focus groups with providers, staff, and patients, and will
explore satisfaction, intervention adoption, and implementation feasibility. We will use methods of qualitative
thematic analysis at three stages. Mixed methods analysis will involve the use of qualitative data to lend insight
to quantitative findings.
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Discussion: This study will make important contributions to the literature on reduced visit models by evaluating a
novel prenatal care model with components to increase patient connectedness (even with fewer pre-scheduled office
visits), as demonstrated on a range of patient-important outcomes. The use of a hybrid effectiveness-implementation
approach, as well as attention to patient and provider perspectives on program components and implementation, may
uncover important information that can inform long-term feasibility and potentially speed future translation.
Trial registration: Trial registration identifier: NCT02082275
Submitted: March 6, 2014
Keywords: Prenatal care, Patient-focused care, Health services research, Program evaluation
Background
Prenatal care is a key preventive health service used in
developed countries around the world. By providing
expectant mothers with regular health evaluations and
information about the course of the pregnancy, labor,
birth, and parenthood, prenatal care aims to reduce the
risk of unfavorable pregnancy and birth outcomes. Most
prenatal care occurs in the setting of routine office visits.
In the U.S., the American College of Obstetricians and
Gynecologists (ACOG) recommends a uniform prenatal
visit schedule comprised of approximately 14 visits: every
four weeks up to 28–32 weeks of gestation, then every
two weeks up to 36 weeks, and finally weekly until birth
[1]. This rhythm of care has been codified largely based
on tradition that is informed by a plan of care directed at
the detection of risks such as hypertensive disorders of
pregnancy. However, research does not necessarily sup-
port high numbers of visits for the majority of low-risk
pregnancies [2, 3]. Indeed, there is a wide variation in visit
schedules across countries, and higher numbers of visits
do not necessarily correspond with better outcomes [3].
While there is no doubt that prenatal care is important to
maternal and fetal health, there is limited evidence of an
exposure-response relationship between visit frequency
and outcomes [4].
In 1989, the Expert Panel on the Content of Prenatal
Care issued recommendations for prenatal care that
were based on expert review and consensus of the lim-
ited best available evidence [5]. These included a recom-
mendation that the visit schedule be flexible and based
on the needs of each expectant mother, for example
more visits for nulliparous and high-risk women and
fewer visits for multiparous and low-risk women. Subse-
quently, several studies have considered the effectiveness
of reduced antenatal care schedules. Most have found
that a reduced schedule of visits among low-risk women
could be implemented without increasing adverse mater-
nal or fetal outcomes such as preterm delivery, pre-
eclampsia, and low birth weight [6–12], although there
is mixed evidence on perinatal mortality [11, 13]. Some
studies found patient satisfaction was unchanged [6] or
improved [9, 10], but a larger number suggest that
patient satisfaction decreases with lower numbers of
visits [7, 8, 11, 14].
Reasons for reduced satisfaction are unclear. Sikorski
et al. found patients receiving a reduced schedule were
less likely to feel listened to and more likely to want
more time to talk at visits [7]. More than 50 % of the
study participants felt that some gaps between visits
were too long. Novick’s qualitative assessment of
women’s preferences for prenatal care included continu-
ity of care, flexibility, comprehensiveness of care (includ-
ing access to group discussions with other pregnant
women), developing meaningful relationships with pro-
fessionals, and becoming more active participants in care
[15]. Structural barriers like inconveniences of office
visits can limit women’s access to prenatal care [16].
Since the expert panel’s report 25 years ago, and des-
pite general consensus on the safety and effectiveness of
a reduced visit schedule on maternal and fetal outcomes,
new models that address women’s preferences have not
been widely adopted [17]. Some investigators suggest
that the effectiveness of prenatal care should not be de-
fined solely in terms of risk assessments and number of
prenatal office visits, but rather in terms of the content
of the care [18, 19]. New models of care that address ac-
cess and continuity of care while reducing the burden of
pre-planned office visits could result in increased patient
satisfaction. However, there is limited research on new
models that go beyond adaptation of the visit schedule.
Developing a new model of care
In 2011, members of the Obstetrics Division at Mayo
Clinic (Rochester, MN), together with the Mayo Clinic
Center for Innovation (CFI) design team, developed a new
model of care for low-risk pregnancies that reduced office
visits while increasing virtual connections with nurses and
providers. This prenatal care program (OB Nest) was to
be based on proactive and direct support from a nursing
team that could meet the on-demand needs of expectant
mothers as they arise, redesigning the need for and timing
of planned on-site appointments with providers while
increasing expectant mothers’ experience of and satisfac-
tion with their care.
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Their theory of action was that the traditional model
of prenatal care predates methodological and techno-
logical advances in pregnancy monitoring and communi-
cations, assuming a rhythm of care dependent on face-
to-face visits that preceded an appreciation for the busy
lives of women. Furthermore, it engendered the idea that
the prenatal office visit is the sole intended point of con-
tact for expectant mothers with their care team, shifting
the locus of control to the provider as in disease treat-
ment models, thus medicalizing the pregnancy experi-
ence. Pregnant women may associate the high frequency
of visits in the traditional model with safe pregnancy
outcomes. In developing the OB Nest care model, the
team hypothesized that empowering low-risk pregnant
women to retain more control of their prenatal care
shifts their health care delivery from a sickness model to
a wellness model.
As a result, the team designed and rapid-tested poten-
tial components of the new program (summary informa-
tion available at www.mayo.edu/center-for-innovation/
projects/ob-nest/). The following were selected for inclu-
sion in OB Nest: Online Care Communities, At-Home
Measurement, Video Appointments (with the option of
phone where video is not available), and Proactive Calls.
This paper reports the study protocol for the evaluation
of the OB Nest program (Fig. 1).
Study purpose
The purpose of this study is to determine the effectiveness
of the OB Nest program, compared to usual prenatal care
in this practice, and to evaluate the implementation
process. The primary research and evaluation questions
are as follows:
1) Does OB Nest improve patient-reported satisfaction
with care, as well as pregnancy-related stress and
perceived quality of prenatal care?
2) Does OB Nest reduce the rate of in-clinic health
care utilization without impacting maternal/fetal
outcomes or fidelity to the process of care standards
specified by ACOG?
3) Can OB Nest be implemented as intended during




This study uses a hybrid effectiveness-implementation
design in a single center randomized controlled trial
(RCT) to compare the OB Nest intervention to usual
care among low-risk pregnant women. Specifically, this
is a Type 1 hybrid design as described by Curran and
colleagues whereby the primary aim is a test of an inter-
vention’s clinical effectiveness but there is also an a
priori aim related to observing and gathering data on
implementation [20]. Embedding process evaluation in
an experimental design like an RCT allows researchers
to answer both “Did it work?” and “How or why did it
work (or not work)?” when studying complex interven-
tions like those in health services [21]. This approach
also has the potential to speed clinical uptake by deliver-
ing information on the intervention’s effectiveness in the
Fig. 1 OB Nest intervention components
Ridgeway et al. BMC Pregnancy and Childbirth  (2015) 15:323 Page 3 of 11
study setting alongside data to inform external validity,
such as the barriers and facilitators to widespread imple-
mentation [20, 22].
Mixed methods are well-suited for these types of
implementation studies, where quantitative methods are
used to test effectiveness and qualitative methods are
used to understand process, participant perspectives
(practitioners and consumers), and the intervention con-
text [23, 24]. In this study, the quantitative methods are
dominant (QUAN), supporting the primary aims of the
study, and the qualitative methods are less dominant
(qual). QUAN and qual data collection, as well as data
analysis, will occur concurrently or simultaneously in a
parallel mixed design [24].
Guiding framework
We used the RE-AIM framework to guide the evaluation
plan, including the selection of mixed methods [25]. This
framework has been developed specifically to address
questions of implementation, effectiveness, and external
validity in studies conducted in real-world settings. The
dimensions of the framework include: Reach (how willing
the targeted population is to participate in the interven-
tion), Effectiveness (the impact of the intervention on
outcomes), Adoption (whether the intervention can be
adopted with ease and minimal modifications), Implemen-
tation (what are the special issues and barriers to imple-
mentation), and Maintenance (can the intervention be
maintained and will the impact continue).
To assess Reach, we will compare patient characteris-
tics (eg, age) between those who agreed to participate in
OB Nest and those who declined participation. This will
allow us to measure participation and representativeness
of the trial. We will also record the reasons that de-
cliners gave to the study coordinator, and for ineligible
patients we will track reasons for ineligibility. We will
use a number of patient-reported outcome measures
and clinical or practice-level outcome measures to assess
Effectiveness on study outcomes including satisfaction,
quality of care, stress, safety and utilization. To assess
Adoption, we aim to understand the extent to which
patients use OB Nest components, as well as the
organizational or individual barriers and facilitators to
provider and staff participation in OB Nest, including
values and preferences. We anticipate that patients will
vary in adoption of the various OB Nest components as
the care model is meant to be patient-driven. To assess
Implementation, we will seek to determine whether the
intervention has been implemented as planned, and po-
tential issues that need immediate adaptation before
full implementation post-study would be possible. Con-
sidering the length of the study, we will not be able to
fully assess Maintenance, but data on effectiveness and
implementation should provide preliminary insights as
to whether we can maintain this intervention post-study.
Table 1 outlines the outcomes and quantitative and quali-
tative data collection methods, as described below, using
the RE-AIM framework. This approach is well suited for
the evaluation of complex, multi-component interventions
like OB Nest where the aim is to evaluate not only overall
program effectiveness but the potential for successful
translation and sustainability.
Setting
This study will recruit individuals from the Obstetrics
Division at Mayo Clinic (Rochester, MN), a tertiary
Midwest teaching hospital with a delivery rate of 2400
women annually. The practice consists of 14 full-time
obstetricians, 5 maternal fetal medicine specialists, 10
certified nurse midwives (CNM), and 10 family medicine
physicians. A 20 bedded level 3 neonatal intensive care
unit serves as a regional referral center and is staffed by
4 full-time neonatologists. The usual model of prenatal
care includes a set schedule of 12 pre-planned in-office
visits with a physician or a certified nurse midwife
(sometimes referred to as “providers” in this article).
CNMs in this practice are registered nurses with Master
of Science degrees in midwifery, and they provide a full
range of prenatal care and labor and delivery services.
Registered nurses in the department assist with patient
care and provide patient education during provider
office visits and in patient education courses. They also
provide support to patients by telephone.
Sample size
On average 2400 pregnant women receive prenatal care
from the Obstetrics Division in a 12-month period, and
about 60 % of these are considered to be low-risk preg-
nancies. We will enroll 300 patients in this study (150
patients per arm). This accounts for a withdraw/post-
randomization exclusion rate as high as 10 %, so the
effective sample size can be as low as 135 patients/arm.
Sample size calculations are displayed in Table 2.
We will interview up to 40 patients and conduct ap-
proximately 4 patient focus groups of 10–12 participants
each. We will also interview physicians (n = 6) and con-
duct focus groups with midwives (n = 9), nurses (n = 7),
and desk staff/clinical assistants (n = 10) at three points
in time. This sample size is within standards for qualita-
tive research, but we will increase the sample size if
needed to achieve saturation in identifying themes.
Participant recruitment and randomization
Patients will be recruited in clinic at the typical 90-min
appointment scheduled with a registered nurse at ap-
proximately 8 weeks of pregnancy. The targeted patient
population for this study will be low-risk patients. The
study coordinator will ascertain the patient’s interest in
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participating in the study and study eligibility, and a
written consent form will be shared with eligible pa-
tients. Inclusion criteria include age 18 to 36 years at
time of enrollment (older patients excluded under the
definition of advanced maternal age as a criterion for
risk), documented gestational age less than 13 weeks,
pregnancy documented as low risk without a concurrent
medical or obstetric complication, ability to read and
understand English, and ability to provide informed con-
sent. Women will be excluded if they have any of the
conditions listed in the patient enrollment exclusion
criteria [see Additional file 1]. Randomization will be
conducted using a dynamic allocation [26] algorithm
minimizing imbalances across multiple assigned stratifi-
cation factors. Patients will be stratified by enrolling age
(≥35 vs. <35), BMI (>30 vs. ≤30) and parity (0 vs. 1+). A
physician will confirm OB Nest patients’ risk assessment
at the new OB return appointment at approximately
12 weeks gestation, consistent with current practice work-
flow. Patients determined to be high-risk at that time will
be removed from the study (post-randomization exclu-
sion). We expect exclusions to be minimal due to the
Table 1 Data collection method and outcome by RE-AIM criteria
RE-AIM criteria Outcome Method Type of data
Reach Participant and decliner characteristics, decliner reasons, and
ineligibility reasons
Administrative data QUAN
Effectiveness Utilization (eg, in-office visits) Administrative data QUAN
Maternal/fetal outcomes (eg, gestational age at delivery) Administrative data QUAN
Receipt of standard prenatal testing and care (ACOG) Administrative data QUAN
Patient stress Questionnaires QUAN
Patient satisfaction and perceived quality of care Questionnaires QUAN
Patient interviews and focus groups qual
Adoption Extent to which participants use intervention components Patient interviews and focus groups qual
Provider and staff interviews and focus groups qual
Administrative data QUAN
Organizational or individual barriers to intervention use Provider and staff interviews and focus groups qual
Patient interviews and focus groups qual
Document review qual
Implementation Implementation as planned, and issues in implementation Patient interviews and focus groups qual
Provider and staff interviews and focus groups qual
Document review qual
Maintenancea
Abbr: QUAN = quantitative, qual = qualitative, ACOG = American College of Obstetricians and Gynecologists
aEffectiveness data and implementation data will inform maintenance, but maintenance will not be fully assessed due to the study length
Table 2 Sample size calculations






Satisfaction with care 108.4 (SD 14.4) 115.6 98 %
Perceptions of quality of care 83.9 (SD 22.8) 91.9 86 %
Prenatal stress 12.9 (SD 7.1) 16.5 98 %
Maternal/fetal outcomes and standards of care
Low birth weight 11 % 6 % 24 %
Gestational age at delivery 38.9 (SD 2.5) 40.2 99 %
Standard of prenatal care (measured as receiving at least 20
out of 24 items from the ACOG standards of prenatal care list)
90 % 95 % 30 %
Health care utilization
Number of antenatal visits 14.7 (SD 4.2) 12 99 %
Abbr: ACOG = American Congress of Obstetricians and Gynecologists
aAll calculations 2-sided with alpha of 0.05. Continuous outcomes compared to a half of standard deviation increase
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clarity of inclusion/exclusion criteria and the availability of
physicians as needed for patient eligibility questions
during the initial 8-week visit.
Patients randomized to the OB Nest program will be
assigned to a dedicated nursing care team comprised of
three registered nurses, and they will be scheduled for 8
pre-planned office visits with a provider (physician or
CNM) compared to 12 in the usual care group, as shown
in Table 3. The 4 office visits will be replaced with con-
nected care visits (phone or online patient portal) with
one of the nurses, whom patients can also contact with
on-demand questions. There will also be two additional
connected care visits in the OB Nest schedule, making
total contacts greater in the OB Nest group, even though
office visits are reduced. An electronic population man-
agement registry was developed on the Caradigm platform
for care team management of OB Nest patients. Patients
will be listed for the week that the nurse team is to contact
them, and lab and imaging tests that have been completed
will populate the registry in real time from the electronic
medical record. The registry will also send data (task lists)
to the clinical team daily based on the protocol of care de-
signed for this initiative.
Patients will be able to request additional in-office visits
if desired and providers may suggest additional in-office
visits to monitor maternal or fetal concerns. Laboratory
tests, imaging, and standardized evaluations will be con-
ducted in both arms of the study. OB Nest patients will be
invited to participate in an online, nurse-moderated com-
munity with other OB Nest participants, where they can
seek advice and support from their peers. Finally, OB Nest
patients will be provided a fetal Doppler and automated
Table 3 Comparison of visit schedule by week of gestation, usual care and OB Nest groups
Week Usual care group OB nest group Care provided (both groups)
1-7 Drop-in pregnancy education Drop-in pregnancy education Interactive self-education
8 New OB office visit with registered
nurse/CNM
New OB office visit with
registered nurse/CNM
Individualized pregnancy education,
bedside ultrasound, history, lab
ordering, discuss genetic options
12 New OB office visit with
physician/CNM
New OB office visit with
physician
Physical exam including pap if
needed and review plan of care
16 Connected care visit with
registered nursea






24 Routine OB office visit with
physician/CNM
Connected care visit with
registered nursea
Routineb
28 Routine OB office visit with
physician/CNM
Routine OB office visit with
physician/CNM
Routineb (lab ordering)
33 Routine OB office visit with
physician/CNM
Connected care visit with
registered nursea
Routineb
36 Routine OB office visit with
physician/CNM
Routine OB office visit with
physician/CNM
Routineb (lab ordering)
38 Routine OB office visit with
physician/CNM
Connected care visit with
registered nursea
Routineb
39 Routine OB office visit with
physician/CNM
Routine OB office visit with
physician/CNM
Routineb
40 Routine OB office visit with
physician/CNM
Connected care visit with
registered nursea
Routineb
41 Routine OB office visit with
physician/CNM; registered
nurse visit; ultrasound
Routine OB office visit with
physician/CNM; nurse visit;
ultrasound
Over 40 weeks bi-weekly monitoring
1 week Postpartum Connected care visit with
registered nursea
Education and review of care
8 weeks Postpartum Routine OB visit with
physician/CNM
Routine OB Office visit with
physician/CNM
Total visits to clinic 12 8
Abbr: CNM = Certified Nurse Midwife
aConnected care visits with nurses are scheduled contacts by phone or online patient portal
bRoutine = Check maternal blood pressure, maternal weight, and fetal heart rate, and provide education
Compared to usual care, OB Nest patients will have 4 fewer office visits. However, total scheduled contacts during pregnancy are greater in the OB Nest group. In
addition to changing provider office visits with nurse virtual connected care visits, there are additional nurse contacts at 16 weeks and one week postpartum
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blood pressure machine for home use, along with train-
ing on how to use the equipment. This equipment will
allow patients to monitor their health and provide an
opportunity for others to be involved in these experi-
ences outside of office visits. Patients will be asked to
keep a weekly journal of weight, fetal heart rate, and
blood pressure readings and report those to nurses at
the connected care visits.
Data collection
Quantitative (QUAN)
Patient characteristics will be collected for patients in
both arms (n = 300) at time of enrollment through self-
report and medical record review including: age, race/
ethnicity, education level, marital status, body mass
index (BMI), due date, parity, previous miscarriage, pre-
vious C-section, and insurance. The following patient-
reported outcome instruments, administered by email
or by mail if requested, will be used to provide data on
locus of control (collected as a measure of participant
characteristics at baseline), satisfaction with care, qual-
ity of care, and stress related to pregnancy in both
arms:
 The validated Fetal Health Locus of Control Scale
will be used at the time of enrollment to assess
patients’ feelings of control in their pregnancies [27].
The scale contains 18 items, with 6 questions per
subscale that address internal control, control by
health professionals and control by God/fate/chance.
Points will be summed and reported on each
subscale.
 Patient satisfaction (primary outcome) with care will
be assessed using the validated 16-item Satisfaction
subscale, which is scored on a 5-point scale from
‘very dissatisfied’ to ‘very satisfied.’ The scale will be
collected at the 36-week assessment [28]. Responses
will be summed and converted to a 0–100 point
scale where higher scores are indicative of a higher
degree of satisfaction.
 Patient perceptions of quality of care will be assessed
using the validated Prenatal Interpersonal Processes
of Care (PIPC) scale [29]. The 30 items cover 3
subscales that address communication, decision
making and interpersonal style. The scale will be
collected at the 36 week assessment. Responses will
be converted to a 0–100 scale for each subscale.
 Stress will be evaluated using the validated PreNatal
Maternal Stress (PNMS) scale [30]. The 9-item scale
will be emailed to patients at approximately 14 weeks
gestation and again with additional items at approxi-
mately 24 weeks and 26 weeks gestation. Scores will
be summed and averaged where higher scores are
indicative of a higher degree of stress.
Data from the medical record will be abstracted to
capture utilization, fidelity to standards of prenatal care,
and maternal/fetal outcomes. The time frame for collec-
tion will be from time of enrollment to the 6–8 week
postpartum appointment. Medical record review will be
conducted to capture all in-office obstetrics visits,
assessments in the out-patient OB triage center, and
hospitalizations. It will also be used to track clinically-
important outcomes including incidence and dates of
pre-eclampsia/eclampsia, hypertension, anemia, urinary
tract infection, hematocrit, infection, and loss of preg-
nancy. Assessment at the time of delivery will include
maternal weight gain, type of delivery, length of stay
during hospitalization, gestational age at delivery, birth
weight, and Apgar scores. To assess compliance with
standard processes of care, study staff will review the
medical record for patients in both arms against a list of
ACOG standards of prenatal care, for example depres-
sion screening, HIV testing, prenatal vitamin/iron sup-
plement prescription, offering influenza vaccine, and
screening for gestational diabetes.
Utilization data from the medical record will be sup-
plemented by data from an internal data tracking system
used to detail OB Nest patient and nursing contact,
including numbers of phone calls, on-line visits, and
conversations through the secure online patient portal.
Nurses will also track time spent on OB Nest patient
care in a department time tracking system. These data,
along with average assessments of time spent on in-
office visits (provider, rooming nurse and desk staff ) and
FTE calculations provided by department financial staff,
will be used to assess staffing demands in both arms.
Qualitative (qual)
Qualitative one-on-one interviews and asynchronous on-
line focus groups (online discussion boards where indi-
viduals are not required to participate in real-time) will
be used to gather data on perceptions of quality and
satisfaction. OB Nest participants will be sampled from a
list of those who indicated interest during the consent
process. We hypothesize that a woman’s experience will
differ by whether she is a first time mother or not, so we
will stratify based on parity.
We will complete individual semi-structured interviews
with up to 40 OB Nest patients. Interviews, conducted by
a trained qualitative interviewer, will be approximately 30-
min in length and typically conducted by phone. Because
we want to interview patients after significant exposure to
intervention activities, we will aim to conduct the inter-
view when the patient reaches 28 and 32 weeks gestation.
Patient focus group data collection (4 groups of 10–12
patients each) will begin after interview data collection.
The asynchronous online focus groups will be open for a
week, with new topics and questions posted each day by
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the moderator (a member of the research team). The
topics and questions will be semi-structured and based on
the initial analysis of the individual patient interviews. The
online asynchronous nature of the groups means partici-
pants will be able to sign on at a time and place that is
convenient for them.
Interviews and discussions with providers, nurses, and
desk staff/clinical assistants will be used to gather infor-
mation on staff perceptions of the intervention and its
implementation. We will invite all physicians, nurse
midwives, nurses, desk staff, and clinical assistants
involved in the study to provide qualitative data. Data
collection will happen at three time points during the
study: baseline (first month of the study), mid-point, and
end of study. Interview guides will be semi-structured
and will include questions based on the RE-AIM frame-
work, as well as Normalization Process Theory, which is
a sociological theory of the implementation, embedding,
and integration of new technologies and organizational
innovations in complex settings [31, 32]. This theory in-
formed questions on how providers and staff understand
the purpose of OB Nest and its value in their practice,
how they perceive the impact it will have on their work,
whether appraisal has led to changes in practice, and
whether people are engaged in driving the initiative
forward, for example.
Finally, document review, which will involve capturing
the written documents from OB Nest implementation
(eg, presentations and memos about OB Nest), will further
help us understand how it was perceived and what
contextual factors may have shaped implementation.
Analysis plan
Quantitative (QUAN)
Quantitative analysis will be performed according to the
intention to treat principle, including all participants in
the arm to which they were randomized, regardless of
whether they received the intervention assigned or crossed
over to the other treatment arm. Baseline characteristics
will be reported in the study results with continuous
values being reported as means and standard deviations
and categorical values reported as counts and frequencies
and compared between study arms using t-tests and chi-
squared tests, respectively.
We will use standard techniques appropriate for par-
ticipant level randomized trials, with each outcome com-
pared between study arms using t-tests for continuous
outcomes and chi-square tests for dichotomous out-
comes. Any baseline imbalances (p < 0.05) will be ex-
plored as a possible factor to adjust for when the
outcome measures are analyzed. We will use predeter-
mined criteria for missing data when calculating scores
on patient-reported surveys. The comparison of
outcomes will be considered significantly different be-
tween arms at a P < 0.05.
Participants who move into a high risk category after
12 weeks will stay on study and be evaluated in the arm
to which they were randomized. If more than 10 % of
patients choose to crossover from intervention to con-
trol, a sensitivity analysis will be conducted. Trial enroll-
ment, completeness of data collection, and fidelity of
follow-up procedures will be reviewed and reported dur-
ing study team meetings which will be conducted on a
monthly basis. Analysis of quantitative data will be per-
formed at the close of the study.
Qualitative (qual)
Audio-recorded interviews will be transcribed verbatim,
de-identified, and verified against actual recordings by
study staff. In-person focus groups will be audio-recorded
and both the moderator and an observer will complete
observational notes for analysis. The analysis team will
review these audio recordings for completeness of cap-
tured data in the notes. Online focus group transcripts will
be captured electronically.
We will use methods of qualitative thematic analysis
with interview and focus group data, as well as in the
document analysis [33, 34]. This approach begins with
familiarization with the data. The next step is to identify
key issues and concepts that will form the basis of a cod-
ing framework. This framework will be independently
applied to the interview and online focus group tran-
scripts by two members of the research team who will
then meet to come to consensus on coding. Qualitative
analysis software (NVivo 10.1, QSR International Pty Ltd.)
will be used to facilitate data organization. Coded data will
be reviewed by the research team who will begin to iden-
tify thematic findings in the data, comparing the data from
these perspectives of participants against observational
notes and documents to gain a rich picture of context
and experience. Data will be analyzed within and across
groups (patients, physicians, midwives, nurses, and desk
staff ). This process will happen in three stages (base-
line, mid-point, and end of study), with each stage
building on knowledge from earlier stages. Throughout
this process we will engage the clinical study team for
input on findings and interpretation.
Mixed methods
One function of mixed methods is expansion, or using
one method to explain the results of another [23]. At the
end of the study, mixed methods analysis will involve
comparing results to increase understanding, specifically
the use of qualitative data to lend insight to quantitative
findings. This includes patient satisfaction and quality of
care, as patient perspectives from interviews and focus
groups will be analyzed against validated questionnaires
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to see if these data can help inform findings. Qualitative
data on implementation, specifically data on how patients
and providers/staff use the intervention and how it oper-
ated in practice, may also complement findings on effect-
iveness. This type of mixed methods analysis will serve as
methods triangulation (checking the consistency of find-
ings generated by different methods) [24, 33].
Ethical considerations
All participants will complete written informed consent
and be told that they can withdraw from the study at
any time. This research was approved by the Mayo
Clinic Institutional Review Board (IRB #13-009513) and
is registered in ClinicalTrials.gov (trial registration iden-
tifier: NCT02082275).
Reporting of study findings
We will adhere to the CONSORT guidelines [35, 36] for
reporting RCTs to transparently report study results and
ensure that sufficient information is included to allow
for assessment of the study’s internal and external validity
[35, 36]. We will use the consolidated criteria for reporting
qualitative research (COREQ) in reporting qualitative
findings, including the search for negative cases when de-
termining saturation or the point at which no new themes
are emerging from the data [37].
Discussion
In spite of a substantial body of evidence that demon-
strates the safety of reduced visit prenatal care models,
practices have been slow to adopt this model of care
[17]. This reluctance may in part be due to the results of
studies that show lower patient satisfaction with reduced
visit schedules [7, 8, 11, 14]. A new model of care that
reduces pre-planned office visits but also increases vir-
tual or other connections with staff and other pregnant
women, leveraging new technologies for communica-
tions and connectedness, could address lingering con-
cerns about patient satisfaction on issues of continuity
of care and feelings of being supported. This wellness-
focused model could also empower women in directing
their care. Early pilot testing of OB Nest supported the
theory of action around how the program should work to
affect outcomes, for example that empowering women in
their care would increase satisfaction, but the team needed
evidence of OB Nest’s effectiveness before moving forward
with practice change.
Early discussions between research team members
started around designing a RCT to test not only effective-
ness on fetal and maternal outcomes currently in the
literature, but also on patient-important measures like sat-
isfaction. This rigorous approach would make important
contributions to the literature on reduced visit models by
including an expanded set of outcomes that would address
lingering questions. However, the team quickly moved
toward a hybrid effectiveness-implementation approach
with a priori aims that would uncover important informa-
tion about how the intervention was actually implemented
in a real world setting. The RE-AIM framework focused
our efforts on understanding a range of outcomes includ-
ing the feasibility of implementation, which is a critical
step in determining long-term feasibility and external val-
idity, ultimately facilitating translatability of evidence into
practice.
Limitations and strengths
Strengths of the study include the use of a range of out-
comes currently not well-represented in the literature,
the hybrid study design that embeds a process evaluation
in an experimental design, and the use of mixed
methods. Previous studies have used one approach or
the other—an experimental design to test clinical out-
comes or qualitative methods to understand participant
perspectives—but this study has the benefit of combin-
ing both into a more complete picture of both “Did it
work?” and “How or why did it work (or not work)?”
Without this more complete analysis, implementation of
new models of care may continue to falter.
The study protocol does come with some risks to
successful execution. One of these may occur when re-
searchers or stakeholder groups have more experience in
one approach than another, resulting in a less integrated
approach. Hybrid designs are also more complicated to
execute [20]. These risks are minimized by the fact that
the study team has broad representation of expertise in
experimental designs, implementation research, and
quantitative and qualitative methods. The clinical team
is also committed to providing insight and feedback in
all phases of the study and ensuring that study results
are useful to clinical decision makers.
The study is also limited by the fact that, while the
experimental design is powered to detect differences
on a range of important outcomes, it is underpowered
to detect statistical difference on some outcomes in-
cluding fetal or maternal death, low birth weight, or
the receipt of standard prenatal testing and care. Fur-
thermore, although reducing office visits and health-
care utilization can yield cost savings, realizing any
cost gains will require structural adjustments to staff-
ing models. If practices fail to capitalize on the op-
portunities for infrastructure change, the OB Nest
program could improve patient and provider satisfac-
tion without realizing the potential economic gains.
Finally, this study is limited by its focus on low-risk
patients, but in-depth reporting on a range of out-
comes may inform future work with other patient
populations.
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Expected impact
We are currently enrolling patients in this study. Upon
completion of this study we will have gained an under-
standing of whether this new model of prenatal care im-
proves patient-reported outcomes, supporting the
clinical team’s theory of action related to what women
want in prenatal care. It will also provide evidence on
whether this model is safe and effective in changing the
paradigm of health care utilization toward interventions
delivered by expert registered nurses and away from
provider-focused care. This is a critical factor as health
care institutions endeavor to improve care while control-
ling costs.
This study has the potential to increase uptake of new
models of reduced visit care, which has faltered even
since the Expert Panel on the Content of Prenatal Care
recommendation in 1989. Hybrid designs and evaluation
frameworks like RE-AIM focus studies like this on exter-
nal validity and the translatability of evidence-based
practice by including methods to understand implemen-
tation [20, 25, 38]. We also aim to add to the growing
literature on embedding process evaluations and qualita-
tive methods in RCTs [39, 40] by addressing the value of
these methods starting in pre-trial planning and fully
reporting how each method is to be used and why each
was selected.
Additional file
Additional file 1: Title of data: Patient enrollment exclusion criteria.
Description of data: List of high-risk factors that would disqualify patients
from participation. (PDF 86 kb)
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JLR, AL, MB, RWH, KN, BSG, LMB, MAM, SMS, EB, and AOF conceived the
study and developed the protocol. JLR, AL, MB, RWH, MAM, SMS, JI, AB, AS,
MB, DF, and RC designed data collection procedures and materials, including
those for patient recruitment and data tracking and analysis. All authors
made contributions that warrant authorship, and all authors read and
approved the final manuscript.
Acknowledgements
We would like to thank the staff and providers who are engaged in the OB
Nest project, especially Douglas Creedon, MD, PhD, Katie Slifko, RN, Nancy Jo
Knutson, RN, and Maureen Lemens, RN. We would also like to acknowledge
the members of the Mayo Clinic Center for Innovation, especially Marnie Meylor,
Daniel O’Neil, Matthew Gardner, and Rachel Hamilton, who worked with the
clinical staff to conceive of and pilot the OB Nest intervention components. This
study is funded with support from the Mayo Clinic Robert D. and Patricia E. Kern
Center for the Science of Health Care Delivery and the Obstetrics Division at
Mayo Clinic.
Author details
1Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery,
Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA. 2Department of
Health Sciences Research, Mayo Clinic, 200 1st Street SW, Rochester, MN
55905, USA. 3Obstetrics Division, Mayo Clinic, 200 1st Street SW, Rochester, MN
55905, USA. 4Office of Risk Management, Mayo Clinic, 200 1st Street SW,
Rochester, MN 55905, USA. 5Practice Administration, Mayo Clinic, 200 1st Street
SW, Rochester, MN 55905, USA. 6Primary Care Internal Medicine, Mayo Clinic,
200 1st Street SW, Rochester, MN 55905, USA. 7Center for Innovation, Mayo
Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
Received: 15 October 2014 Accepted: 25 November 2015
References
1. Kriebs JM. Guidelines for Perinatal Care, Sixth Edition: By the American
Academy of Pediatrics and the American College of Obstetricians and
Gynecologists. J Midwifery Womens Health. 2010;55(2):e37–7.
2. Hall M, Chng PK, Macgillivray I. Is routine antenatal care worth while?
Lancet. 1980;316(8185):78–80.
3. Lobo A. Too much of a good thing? The case for a reduced schedule of
antenatal visits. Pract Midwife. 1998;1(4):19–21.
4. Moos MK. Prenatal care: limitations and opportunities. J Obstet Gynecol
Neonatal Nurs. 2006;35(2):278–85.
5. Rosen MG. Caring for our future, the content of prenatal care: A report of
the Public Health Service Expert Panel on the Content of Prenatal Care.
Washington (DC): U.S. Department of Health and Human Services; 1989.
6. McDuffie Jr RS, Beck A, Bischoff K, Cross J, Orleans M. Effect of frequency of
prenatal care visits on perinatal outcome among low-risk women. A
randomized controlled trial. JAMA. 1996;275(11):847–51.
7. Sikorski J, Wilson J, Clement S, Das S, Smeeton N. A randomised controlled
trial comparing two schedules of antenatal visits: the antenatal care project.
BMJ. 1996;312(7030):546–53.
8. Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gülmezoglu M, Mugford M,
et al. WHO systematic review of randomised controlled trials of routine
antenatal care. Lancet. 2001;357(9268):1565–70.
9. Binstock MA, Wolde-Tsadik G. Alternative prenatal care. Impact of reduced
visit frequency, focused visits and continuity of care. J Reprod Med.
1995;40(7):507–12.
10. Walker DS, Koniak-Griffin D. Evaluation of a reduced-frequency prenatal visit
schedule for low-risk women at a free-standing birthing center. J Nurse
Midwifery. 1997;42(4):295–303.
11. Dowswell T, Carroli G, Duley L, Gates S, Gulmezoglu AM, Khan-Neelofur D,
et al. Alternative versus standard packages of antenatal care for low-risk
pregnancy. Cochrane Database Syst Rev. 2010;10, CD000934.
12. Villar J, Carroli G, Khan-Neelofur D, Piaggio G, Gulmezoglu M. Patterns of
routine antenatal care for low-risk pregnancy. Cochrane Database Syst Rev.
2001;4, CD000934.
13. Vogel JP, Ndema HA, Souza JP, Gulmezoglu MA, Dowswell T, Carroli G, et al.
Antenatal care packages with reduced visits and perinatal mortality: a
secondary analysis of the WHO Antenatal Care Trial. Reprod Health.
2013;10(1):19.
14. Jewell D, Sharp D, Sanders J, Peters TJ. A randomised controlled trial of
flexibility in routine antenatal care. BJOG. 2000;107(10):1241–7.
15. Novick G. Women's experience of prenatal care: an integrative review.
J Midwifery Womens Health. 2009;54(3):226–37.
16. Phillippi JC. Women's Perceptions of Access to Prenatal Care in the United
States: A Literature Review. J Midwifery Womens Health. 2009;54(3):219–25.
17. Gregory KD, Johnson CT, Johnson TRB, Entman SS. The content of prenatal
care: Update 2005. Womens Health Issues. 2006;16(4):198–215.
18. Culpepper L, Jack B. Prenatal visits–it's not the number, it's the content.
Birth. 1996;23(4):236–8.
19. King TL. Prenatal Care for the 21st Century: Outside the 20th Century Box.
J Midwifery Womens Health. 2009;54(3):167.
20. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation
hybrid designs: combining elements of clinical effectiveness and implementation
research to enhance public health impact. Med Care. 2012;50(3):217–26.
21. Oakley A, Strange V, Bonell C, Allen E, Stephenson J. Process evaluation
in randomised controlled trials of complex interventions. BMJ.
2006;332(7538):413–6.
22. Bernet AC, Willens DE, Bauer MS. Effectiveness-implementation hybrid
designs: implications for quality improvement science. Implement Sci.
2013;8 Suppl 1:S2.
23. Palinkas LA, Aarons GA, Horwitz S, Chamberlain P, Hurlburt M, Landsverk J.
Mixed method designs in implementation research. Adm Policy Ment
Health. 2011;38(1):44–53.
Ridgeway et al. BMC Pregnancy and Childbirth  (2015) 15:323 Page 10 of 11
24. Teddlie C, Tashakkori A. Foundations of mixed methods research:
integrating quantitative and qualitative approaches in the social and
behavioral sciences. Los Angeles: Sage; 2009.
25. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of
health promotion interventions: the RE-AIM framework. Am J Public Health.
1999;89(9):1322–7.
26. Pocock SJ, Simon R. Sequential treatment assignment with balancing for
prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103–15.
27. Labs SM, Wurtele SK. Fetal health locus of control scale: development and
validation. J Consult Clin Psychol. 1986;54(6):814–9.
28. Littlefield VM, Adams BN. Patient participation in alternative perinatal care:
impact on satisfaction and health locus of control. Res Nurs Health.
1987;10(3):139–48.
29. Wong ST, Korenbrot CC, Stewart AL. Consumer assessment of the quality of
interpersonal processes of prenatal care among ethnically diverse low-
income women: development of a new measure. Womens Health Issues.
2004;14(4):118–29.
30. Lobel M, Cannella DL, Graham JE, DeVincent C, Schneider J, Meyer BA.
Pregnancy-specific stress, prenatal health behaviors, and birth outcomes.
Health Psychol. 2008;27(5):604–15.
31. May C. A rational model for assessing and evaluating complex interventions
in health care. BMC Health Serv Res. 2006;6(1):86.
32. May C, Finch T. Implementing, Embedding, and Integrating Practices: An
Outline of Normalization Process Theory. Sociology. 2009;43(3):535–54.
33. Patton MQ. Qualitative research and evaluation methods. 3rd ed. Thousand
Oaks: Sage Publications; 2002.
34. O'Cathain A, Thomas K. Combining qualitative and quantitative methods. In:
Pope C, Mays N, editors. Qualitative research in health care. 3rd ed. Oxford,
UK: Blackwell Publishing Ltd; 2006. p. 102–11.
35. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Methods and processes
of the CONSORT Group: example of an extension for trials assessing
nonpharmacologic treatments. Ann Intern Med. 2008;148(4):W60–66.
36. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the
CONSORT statement to randomized trials of nonpharmacologic treatment:
explanation and elaboration. Ann Intern Med. 2008;148(4):295–309.
37. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative
research (COREQ): a 32-item checklist for interviews and focus groups. Int J
Qual Health Care. 2007;19(6):349–57.
38. Glasgow RE, Green LW, Klesges LM, Abrams DB, Fisher EB, Goldstein MG, et al.
External validity: we need to do more. Ann Behav Med. 2006;31(2):105–8.
39. Plano Clark VL, Schumacher K, West C, Edrington J, Dunn LB, Harzstark A, et
al. Practices for Embedding an Interpretive Qualitative Approach Within a
Randomized Clinical Trial. J Mix Methods Res. 2013;7(3):219–42.
40. O'Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Hewison J. What can
qualitative research do for randomised controlled trials? A systematic
mapping review. BMJ Open. 2013, 3(6); doi: 10.1136/bmjopen-2013-002889.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ridgeway et al. BMC Pregnancy and Childbirth  (2015) 15:323 Page 11 of 11
